Peptide Library

In clinical trials

Brain & sleep

Davunetide

Evidence

Clinical trials

Class

Neuroprotective peptide derived from ADNP

/

Davunetide

KEY TAKEAWAY

Davunetide is an eight-amino-acid peptide derived from a protein called activity-dependent neuroprotective protein. It was developed as an experimental drug for neurodegenerative disease. Davunetide is not FDA-approved. A large trial in progressive supranuclear palsy did not meet its main goals, and development for that use was stopped.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Neuroprotective peptide derived from ADNP

Being studied for

Studied in progressive supranuclear palsy and cognitive impairment

Key fact

Davunetide is not FDA-approved. A large trial in progressive supranuclear palsy did not meet its main goals, and development for that use was stopped.

Route

Studied as a nasal spray and by injection

Evidence strength

Clinical trials

What it is

What it is

Davunetide is an eight-amino-acid peptide derived from a protein called activity-dependent neuroprotective protein. It was developed as an experimental drug for neurodegenerative disease.

How it works

How it works

It is thought to stabilize microtubules, the internal scaffolding of nerve cells that tau protein normally supports.

Regulatory status

Regulatory status

Davunetide is not FDA-approved. A large trial in progressive supranuclear palsy did not meet its main goals, and development for that use was stopped.

What it is used for

What it is used for

Studied in progressive supranuclear palsy and cognitive impairment.

Side effects and risks

Side effects and risks

Trials reported mostly mild side effects, but long-term safety data are limited.

Citations

Citations

Davunetide: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo